Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Hosp Infect ; 106(3): 454-464, 2020 11.
Artículo en Inglés | MEDLINE | ID: mdl-32898614

RESUMEN

BACKGROUND: Decades of studies document an association between Gammaproteobacteria in sink drains and hospital-acquired infections, but the evidence for causality is unclear. AIM: We aimed to develop a tool to assess the quality of evidence for causality in research studies that implicate sink drains as reservoirs for hospital-acquired Gammaproteobacterial infections. METHODS: We used a modified Delphi process with recruited experts in hospital epidemiology to develop this tool from a pre-existing causal assessment application. FINDINGS: Through four rounds of feedback and revision we developed the 'Modified CADDIS Tool for Causality Assessment of Sink Drains as a Reservoir for Hospital-Acquired Gammaproteobacterial Infection or Colonization'. In tests of tool application to published literature during development, mean percent agreement ranged from 46.7% to 87.5%, and the Gwet's AC1 statistic (adjusting for chance agreement) ranged from 0.13 to 1.0 (median 68.1). Areas of disagreement were felt to result from lack of a priori knowledge of causal pathways from sink drains to patients and uncertain influence of co-interventions to prevent organism acquisition. Modifications were made until consensus was achieved that further iterations would not improve the tool. When the tool was applied to 44 articles by two independent reviewers in an ongoing systematic review, percent agreement ranged from 93% to 98%, and the Gwet's AC1 statistic was 0.91-0.97. CONCLUSION: The modified causality tool was useful for evaluating studies that implicate sink drains as reservoirs for hospital-acquired infections and may help guide the conduct and reporting of future research.


Asunto(s)
Infección Hospitalaria/prevención & control , Reservorios de Enfermedades/microbiología , Contaminación de Equipos/prevención & control , Equipos y Suministros de Hospitales/microbiología , Infecciones por Bacterias Gramnegativas/prevención & control , Programas Informáticos , Causalidad , Infección Hospitalaria/microbiología , Contaminación de Equipos/estadística & datos numéricos , Gammaproteobacteria , Infecciones por Bacterias Gramnegativas/transmisión , Hospitales/estadística & datos numéricos , Humanos , Control de Infecciones/métodos
2.
Toxicology ; 110(1-3): 9-15, 1996 Jun 17.
Artículo en Inglés | MEDLINE | ID: mdl-8658563

RESUMEN

N-acetyl-beta-D-glucosaminidase (NAG) is one of the sensitive hydrolytic lysosomal enzymes which is released after renal tubular damages. We studied gentamicin-induced nephrotoxicity by determining the NAG release in perfused rat kidney. 100 micrograms/ml of gentamicin caused a time-dependent increase in enzymuria, peaking at 90 min. At this time the released NAG is about sixfold more than the control. The effect of concurrent perfusion with 100 micrograms/ml gentamicin and with 0.5 mmol/l lithium chloride or 0.5 mmol/l rubidium chloride in the perfusion fluid was also studied by measuring NAG activity in the perfusate. Both cations decrease the gentamicin-induced NAG release. However, the inhibitory effect of lithium chloride may be due to interference of this ion with the polyphosphoinositide cycle in renal tubular lysosomal membranes. There is no obvious evidence for an inhibitory effect of rubidium chloride.


Asunto(s)
Acetilglucosaminidasa/metabolismo , Cloruros/farmacología , Gentamicinas/toxicidad , Riñón/efectos de los fármacos , Cloruro de Litio/farmacología , Rubidio/farmacología , Acetilglucosaminidasa/antagonistas & inhibidores , Análisis de Varianza , Animales , Cloruros/administración & dosificación , Relación Dosis-Respuesta a Droga , Inhibidores Enzimáticos/farmacología , Gentamicinas/administración & dosificación , Gentamicinas/antagonistas & inhibidores , Concentración de Iones de Hidrógeno , Riñón/enzimología , Túbulos Renales/efectos de los fármacos , Túbulos Renales/patología , Cloruro de Litio/administración & dosificación , Lisosomas/efectos de los fármacos , Lisosomas/metabolismo , Masculino , Perfusión , Fosfatos de Fosfatidilinositol/metabolismo , Ratas , Ratas Sprague-Dawley , Rubidio/administración & dosificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA